2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine has been researched along with aspirin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ilett, KF; Kadlubar, FF; Minchin, RF; Reeves, PT; Teitel, CH | 1 |
| Mori, H; Ohnishi, M; Rahman, KM; Sugie, S; Suzui, N; Wakabayashi, K; Yoshimi, N | 1 |
| Mori, H; Rahman, W; Sugie, S; Suzui, N | 1 |
3 other study(ies) available for 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine and aspirin
| Article | Year |
|---|---|
Direct O-acetylation of N-hydroxy arylamines by acetylsalicylic acid to form carcinogen-DNA adducts.
Topics: Acetylation; Aminobiphenyl Compounds; Aspirin; Carcinogens; DNA; Fluorenes; Imidazoles; Quinolines; Quinoxalines | 1992 |
Inhibitory effects of diallyl disulfide or aspirin on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary carcinogenesis in rats.
Topics: Administration, Oral; Allyl Compounds; Animals; Anticarcinogenic Agents; Aspirin; Carcinogens; Corn Oil; Dietary Fats; Disulfides; Eflornithine; Female; Imidazoles; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley | 1997 |
Chemoprevention of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine-induced mammary carcinogenesis in rats.
Topics: Allyl Compounds; Animals; Anticarcinogenic Agents; Aspirin; Benzoflavones; beta-Naphthoflavone; Carcinogens; Disulfides; Drug Antagonism; Eflornithine; Female; Hydroxybenzoates; Imidazoles; Indoles; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley | 1999 |